CLINICAL ROLE -
Carfilzomib, Lenalidomide, and Dexamethasone: A Curative Approach for Smoldering Multiple Myeloma
In the results, 31% of patients maintained undetectable measurable residual disease 4 years after treatment.
Read More
Emerging Frontiers: The Gut Microbiome Plays an Important Role in Enhancing Cancer Immunotherapy and Treatment Outcomes
Gut microbiome research is no longer an obscure field in cancer care.
Survey: 50% of Active Drug Shortages in the United States Persist for 2 or More Years
ASHP investigators determined the severity and impact of ongoing drug shortages, with approximately 99% of respondents reporting that they experienced a shortage.
October 2024 Condition Watch: COVID-19
IVIG Prescriptions Guideline-Appropriate in Majority of French Adults With Severe Immune Thrombocytopenia
Intravenous immunoglobulin prescriptions deemed non-compliant according to French national guidelines were more common in younger patients.
Smoking Cessation Within 6 Months of Cancer Diagnosis Boosts Survival Rates for Patients With Lung Cancer
Following lung cancer diagnosis, adjusting lifestyle habits can improve treatment responses.
Lung Cancer Screenings Can Save Lives, Yet Uptake Remains Low
Further efforts may be required to urge eligible members of the public to get screened for lung cancer.
Simultaneous Zoster, Inactive Quadrivalent Influenza Vaccination Shows Acceptable Safety for Older Adults
The simultaneous doses of both vaccines compared with individual RZV and quadrivalent high-dose inactivated influenza vaccine (HD-IIV4, Fluzone; Sanofi) had similar overall safety findings.
Early Treatment With Sebetralstat Correlates With Shorter Duration of Hereditary Angioedema Attacks
Patients with hereditary angioedema who received sebetralstat earlier had faster complete resolution of their attacks.
The Needs of One Are the Needs of Many: Everyone Counts in Health Care
A patient with BPDCN finds her champion.
Advanced Therapies Redefine Survival for Patients With Breast Cancer
Targeted therapies, CDK4/6 inhibitors, and precision medicine are improving outcomes for patients with high-risk and metastatic disease.
Global Oncology Trends Highlight Rising Cancer Costs, Access Disparities, and Treatment Innovations
Rising cancer rates and costs pose challenges in global oncology markets amid AI and targeted therapy breakthroughs.
From Diagnosis to Delivery: How Multidisciplinary Teams Tackle Stage 3A Lung Cancer
Experts from Moffitt Cancer Center discuss the benefit of multidisciplinary teams in lung cancer care.
Because Ned Said: As the Election Looms, Will Drug Price Negotiations Sway Voters?
Although patients hope for reduced costs, Pharma’s reaction to the IRA remains to be seen.
Pharmacists Can Directly Improve Health Literacy
Incorporating the teach-back method and providing patient handouts expand health knowledge.
NCODA Fall Summit Recap: Key Sessions and Expert Interviews From the 2024 Meeting
The 2024 NCODA International Fall Summit took place in Orlando, Florida, from October 23 to October 25.
FDA Accepts Biologic License Application for Biosimilar Denosumab
HLX14 (Organon) is an investigational biosimilar to denosumab (Prolia/Xgeva; Amgen).
BPA Exposure May Increase Risk of Mortality in Adults With Hyperlipidemia
Bisphenol A (BPA) is a chemical compound that is linked to various adverse health effects.
Public Concern of RSV Infection Has Decreased as Flu and COVID-19 Remain a Worry
Findings suggest further need to educate the public on receiving an indicated vaccine as we approach peak respiratory syncytial virus (RSV) season.
Emerging Therapies and Precision Medicine Offer Promising Results in Hepatocellular Carcinoma and Biliary Tract Cancer
Advancements include novel combination therapies and improved diagnostic techniques.
Patients With Inflammatory Bowel Disease Face Modest Increase in Risk of Lymphoma
The risk of developing lymphoma remained nearly the same between patients with Crohn disease and ulcerative colitis.
Did Vampire Myths Originate From a Blood Disorder?
Conversations About SDOH Are Difficult but Vital
Initiating such discussions can be hard, but they can greatly affect health outcomes.
Researchers Find “Digital Twin” Model Accurately Predicts Treatment Responses for Different Chemotherapy Drugs
This model, which uses technology that discovers black holes, pulls from real data to evaluate cancer treatments, optimizing treatment choices for patients with different cancers.
Sublingual Epinephrine Film Promptly Resolves Symptoms in Patients With Oral Allergy Syndrome
Results indicate that sublingual epinephrine can resolve symptoms, including swelling of the face and throat, associated with oral allergy syndrome in minutes.
Protecting Pharmacy Technicians: Key Practices in Hazardous Drug Compounding
Liz Vogel, CPhT-Adv, CSPT, discusses the procedures and best practices for safe compounding of hazardous and non-hazardous drugs.
The Lost Girls: Unmasking ADHD in Adult Women
Evolving understanding of attention deficit hyperactivity disorder (ADHD) underscores the need for inclusive research and support, especially for women.
Insights Into ADHD Diagnoses in Adult Women
Judith Joseph, MD, MBA addressed ADHD misdiagnosis, symptoms, and effective treatments.
Watch
FDA Grants Accelerated Approval to Asciminib for Adult Patients With Newly Diagnosed Ph+ CML-CP
The accelerated approval comes after 48-week major molecular response rate data.
Researchers Begin Phase 3 Trial Assessing Adjuvant V940 With Pembrolizumab to Treat Non–Small Cell Lung Cancer
The INTerpath-009 trial assessed a combination of V940 with pembrolizumab among individuals with stage II, IIIA, IIIB (N2) non–small cell lung cancer.
